David M Stout

Non Executive / Other Non-Executive
  • Director Verified:
  • No
Login/ Register  to follow report
Company:

About

David Stout has served as a director of Jabil since September 2009. Mr. Stout was President, Pharmaceuticals, GlaxoSmithKline (GSK), with responsibility for global pharmaceutical operations, from 2003 to 2008. Prior to that, he served as President, U.S. Pharmaceuticals at GSK from 1999 to 2003, and as Senior Vice President, Sales and Marketing U.S., for SmithKline Beecham (SB) from 1996 until 1999. Prior to his time at SB and GSK, Mr. Stout held positions of increasing responsibility at Schering-Plough Corporation, from 1979 until 1996, including President of Schering Laboratories. He also serves on the board of directors of BlueWillow Biologics, a privately held company, and he previously served on the boards of Pharnext SA from 2018 to 2020, and Idorsia, LTD from 2017 to 2019, both biopharmaceutical companies, as well as Airgas Incorporated, Shire Pharmaceuticals and Actelion Pharmaceuticals, Ltd.

 

Personal Details

Title: Mr
Surname: Stout
DoB: 01/01/1956
Age: 70 years
M/F: Male
Nationality: American
Country of Birth: United States of America
Language: English
Qualification: BS(Biology)
Industry:

 

Qualifications & Experience

 

Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:

 

Other directorships (state)

(only entities turnover at least $5m p/a)

 

Working history

Name

Member

GlaxoSmithKline plc
Appointed Date: 01/01/2003
Date Resigned: 01/01/2008
Industry: Healthcare

View Company

 

Committee/s

CompanyCommitteeRoleAppointment DateResignation Date
JabilBoardMember01/09/2009
JabilNominations & GovernanceMember01/09/2009

 

Independence Questions

Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.
Download PDF